SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-021702
Filing Date
2023-04-28
Accepted
2023-04-28 17:16:46
Documents
20

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20007987x2_def14a.htm   iXBRL DEF 14A 1241898
6 logo_rocketpharma.jpg GRAPHIC 29648
7 ny20007987x2_pc01.jpg GRAPHIC 542266
8 ny20007987x2_pc02.jpg GRAPHIC 609533
9 ny20007987x2_pvp01.jpg GRAPHIC 106521
10 ny20007987x2_pvp02.jpg GRAPHIC 103111
11 ny20007987x2_pvp03.jpg GRAPHIC 75195
  Complete submission text file 0001140361-23-021702.txt   5912491

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rckt-20230622.xsd EX-101.SCH 5926
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20230622_def.xml EX-101.DEF 7406
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20230622_lab.xml EX-101.LAB 22784
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20230622_pre.xml EX-101.PRE 24696
14 EXTRACTED XBRL INSTANCE DOCUMENT ny20007987x2_def14a_htm.xml XML 336233
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36829 | Film No.: 23868322
SIC: 2834 Pharmaceutical Preparations